Tenax Therapeutics is trading at $1.96, up 5.95%, after closing at $1.85 on September 2, 2026, with no clear catalyst identified.
- No new company-specific announcement was identified for September 3, 2026.
- The latest release, dated August 29, discussed Phase 3 LEVEL results at ESC Congress 2026.
- A September 1 update concerned a September 9 conference presentation; broader-market support remained limited.